Deprescribing & Polypharmacy at AAPP 2027 Annual Meeting
3 sessions on deprescribing & polypharmacy · April 4–7, 2027, Louisville, KY. Compare deprescribing & polypharmacy at other meetings →
Sunday, April 4
14:40–15:40 · Debate
Choices, Choices: A Debate on Antipsychotic Polypharmacy Care Decisions
Bob Haight · Amy Werremeyer · Austin Campbell
A debate-format session on contentious antipsychotic decisions where guidelines give limited direction, including polypharmacy versus clozapine monotherapy, choosing among long-acting injectables, and handling inadequate response to LAIs.
Antipsychotic Prescribing · Clozapine · Long-Acting Injectables
Monday, April 5
12:20–13:20 · Lecture · Clinical Application Series
Improving Psychotropic Prescribing in Foster Care: The Essential Role of the BCPP
Looks at why youth in foster care often receive complex psychotropic regimens and how board-certified psychiatric pharmacists can support safer prescribing. Covers stewardship approaches, barriers to including pharmacists on foster care teams, and state advocacy efforts.
Child & Adolescent · Collaborative & Integrated Care · Practice, Policy & Workforce
Wednesday, April 7
07:00–08:00 · Lecture · Clinical Application Series
Psychotropic Stewardship from Startup to Sustainability
Offers a practical, stepwise roadmap for building, launching and expanding a psychotropic stewardship program in different practice settings. Covers core program elements and strategies for growth based on resources, staffing and organizational priorities.
Collaborative & Integrated Care · Practice, Policy & Workforce
Other topics at this meeting
Drug Interactions & Safety 5Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Antipsychotic Prescribing 4Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2